Johnson & Johnson Commits $2B to Fujifilm North Carolina Site in Latest US Manufacturing Push

Johnson & Johnson is investing $2 billion* over the next decade to expand a biopharmaceutical manufacturing facility at *Fujifilm's site in Holly Springs, North Carolina1345.

This expansion will result in 120 new permanent jobs at the facility145.

J&J's investment is part of a broader initiative to onshore US biopharmaceutical manufacturing and expand the pipeline of available medicines within the United States14.

The new facility will encompass over 160,000 square feet and aims to strengthen J&J’s advanced medicine manufacturing capacity in the US14.

Earlier in 2025, Johnson & Johnson announced an additional $55 billion commitment over four years to US manufacturing, research & development, and technology investments145.

This move aligns with recent US government incentives and growing trade restrictions—such as threats of increased tariffs on pharmaceutical imports—to encourage domestic manufacturing1.

J&J is planning further announcements for advanced manufacturing sites and expansion of current US facilities in the coming months14.

Sources:

1. https://www.foxbusiness.com/lifestyle/johnson-johnson-investing-2b-us-manufacturing-creating-new-jobs

3. https://firstwordpharma.com/story/5991042

4. https://businessfacilities.com/johnson-johnson-syngene-boost-biopharma-in-north-carolina-maryland

5. https://www.pharmaceuticalcommerce.com/view/johnson-johnson-commits-2-billion-north-carolina-manufacturing-expansion